MarketInOut Stock Screener Log In | Sign Up

HLB Co Ltd

KRX • Healthcare • Biotechnology • Quote as of 10/28/2026 14:30
HLB Co Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeKRX
Market Capitalization5,304,366 mln
Float120 mln
Earnings Date08/18/2025

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-3.15
Reliable

Relative Strength

48 / 100
In line with market

Debt / Equity

0.86
Moderate leverage

Pre-Tax Margin

-160%
Severely loss-making

ROE

-34.51
Deeply negative

Business Description

Founded in 1975 and based in Ulsan, South Korea, HLB Co. Ltd. operates across a wide range of industries. The company builds and services lifeboats and fiberglass pipes, both in South Korea and abroad. It also develops and produces medical and pharmaceutical products, including cancer treatments, biological drugs targeting infectious diseases, and everyday medical supplies such as alcohol swabs. In addition, HLB is active in e-commerce and investment activities.

Key Fundamentals

EPS-1,615
ROE-34.51
RPS738
ROIC-8.96
ROA-16.35
EBITDA, mln-124,941
EV / EBITDA-46.59
EV / EBIT-44.37
Revenue, mln97,467
EV / Revenue59.72

Quote Details

Last 40,400
Change 500 (1.25%)
Open 39,950
Volume 296,692
Turnover 11,986,357,248
Average Volume 1,202,270

Financial Ratios

Pre-Tax Profit Margin-160
Current Ratio0.26
Price / Book13.03
Price / Tangible Book79.40
Debt / Equity0.86
Price / Sales56.17

Financial Strength

Altman Z-Score5.87
Piotroski F-Score 3 / 9
Beneish M-Score-3.15

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -4.6% 27 / 100   
1 Month 32.24% 99 / 100   
2 Months 14.45% 87 / 100   
6 Months -35.26% 32 / 100   
1 Year 1.51% 65 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog